Effects of Long-term Treatment with Proton Pump Inhibitors in Gastro-oesophageal Reflux Disease on the Histological Findings in the Lower Oesophagus

References

• Sonnenberg A, Lepsien G, Müller-Lissner SA, Koelz HR, Siewert JR, Blum AL. When is esophagitis healed? Esophageal endoscopy, histology and function before and after cimetidine treatment. Dig Dis 1982;27:297–302.
   Google Scholar
• Weinstein WM, Bogoch ER, Bowes KL. The normal human esophageal mucosa: a histological reappraisal. Gastroenterology 1975;68:40–4.
   Google Scholar
• Bate CM, Keeling PWN, O’Morain C, Wilkinson SP, Foster DN, Mountford RA, et al. Comparison of omeprazole and cimetidine in reflux esophagitis: symptomatic, endoscopic, and histological evaluations. Gut 1990;31: 968–72.
   Google Scholar
• Siewert JR, Ottenjann R, Heilmann K, Neiss A, Dopfer H. Therapy and prevention of reflux esophagitis. Results of a multicenter study with cimetidine. I. Epidemiology and results of acute therapy. Z Gastroenterol 1986;24:381–95.
   Google Scholar
• Schindlbeck NE, Wiebecke B, Klauser AG, Vorderholzer WA, Müller-Lissner SA. Diagnostic value of histology in non-erosive gastro-oesophageal reflux disease. Gut 1996;39:151–4.
   Google Scholar
• Plein K, Stolte M, Fuchs W, Funken C, Hotz J. Vergleichende Untersuchung der Wirkung von Lansoprazol und Ranitidin auf die Abheilung der akuten Refluxösophagitis. Leber Magen Darm 1998;28:24–32.
   Google Scholar
• Baldi F, Bardhan KD, Borman PC, Brullet E, Dent J, Galmiche JP, et al. Lansoprazole maintains healing in patients with reflux esophagitis. Gastroenterology 1996;110:A–986.
   Google Scholar
• Cameron AJ, Zinsmeister AR, Ballard DJ, Carney JA. Prevalence of columnar-lined (Barrett’s) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology 1990;99:918–22.
   Google Scholar
• Geisinger KR, Teot LA, Richter JE. A comparative cytopathologic and histologic study of atypia, dysplasia, and adenocarcinoma in Barrett’s esophagus. Cancer 1992;69:8–16.
   Google Scholar
• Yang PC, Davis S. Incidence of cancer of the esophagus in the US by histologic type. Cancer 1988;61:612–7.
   PubMed Web of Science ®Google Scholar
• Ismail-Beigi F, Pope CE. Distribution of the histological changes of gastroesophageal reflux in the distal esophagus of man. Gastroenterology 1974;66:1109–13.
   PubMed Web of Science ®Google Scholar
• Ismail-Beigi F, Horton PF, Pope CE. Histological consequences of gastroesophageal reflux in man. Gastroenterology 1970;58:163–74.
   PubMedGoogle Scholar
• Havelund T, Laursen LS, Skoubo-Kristensen E, Andersen BN, Pedersen SA, Jensen KB, et al. Omeprazole and ranitidine in treatment of reflux-oesophagitis: double blind comparative trial. Br Med J 1988; 296:89–92.
   Google Scholar
• Oderda G, Dell’Olio D, Forni M, Farina L, Tavassoli K, Ansaldi N. Treatment of childhood peptic oesophagitis with famotidine or alginat-antacid. Ital J Gastroenterol 1990;22:346–9.
   PubMedGoogle Scholar
• Bell NJV, Hunt RH. Role of gastric acid suppression in the treatment of gastroesophageal reflux disease. Gut 1992;33:118–24.
   PubMed Web of Science ®Google Scholar
• Hallerbäck B, Unge P, Carling L, Edwin B, Glise H, Havu N, et al. Omeprazole or ranitidine in long-term treatment of reflux esophagitis. Gastroenterology 1994;107:1305–11.
   PubMed Web of Science ®Google Scholar
• Dehn TCB, Shepherd HA, Colin-Jones D, Kettlewell MGW, Carrol NJH. Double blind comparison of omeprazole (40 mg od) versus cimetidine in the treatment of symptomatic erosive reflux oesophagitis, assessed endoscopically, histologically and by 24 h pH monitoring. Gut 1990;31: 509–13.
   Google Scholar
• Smith PM, Kerr GD, Cockel R, Ross BA, Bate CM, Brown P, et al. A comparison esophageal stricture. Gastroenterology 1994; 107:1312–8.
   PubMed Web of Science ®Google Scholar
• Mössner J, Hölscher AH, Herz R, Schneider A. Double-blind study of pantoprazole and omeprazole in the treatment of reflux oesophagitis: a multicentre trial. Aliment Pharmacol Ther 1995; 9:321–6.
   PubMed Web of Science ®Google Scholar
• Howden CW, Burget DW, Hunt RH. Appropriate acid suppression for optimal healing of duodenal ulcer and gastro- oesophageal reflux disease. Scand J Gastroenterol 1994;29:79–82.
   Google Scholar
• Sontag JS, Hirschowitz BI, Holt S, Robinson MG, Behar J, Berenson MM, et al. Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: the U.S. multicenter study. Gastroenterology 1992;102:109–18.
   PubMed Web of Science ®Google Scholar
• Spechler SJ, Zeroogian JM, Antonioli DA, Wang HH, Goyal RK. Prevalence of metaplasia at the gastro-oesophageal junction. Lancet 1994;344:1533–6.
   Google Scholar
• Kim SL, Waring JP, Spechler SJ, Sampliner RE, Doos WG, Krol F, et al. Diagnostic inconsistencies in Barrett’s esophagus. Gastroenterology 1995;107:945–9.
   Web of Science ®Google Scholar
• Dent J, Holloway RH, Toouli J, Dodds WJ. Mechanisms of lower esophageal sphincter incompetence in patients with symptomatic gastroesophageal reflux. Gut 1988;29:1020–3.
   PubMed Web of Science ®Google Scholar
• Orlando RC. Reflux esophagitis: overview. Scand J Gastroenterol 1995;30 Suppl 210:36–7.
   Web of Science ®Google Scholar
• Schoeman MN, Tippett MD, Akkermans LMA, Dent J, Holloway RH. Mechanisms of gastroesophageal reflux in ambulant healthy human subjects. Gastroenterology 1995;108:83–91.
   Google Scholar
• Holloway RH, Dent J, Narielvala F, Mackinnon AM. Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole in patients with severe reflux oesophagitis. Gut 1996;38:649–54.
   PubMed Web of Science ®Google Scholar
• Bate CM, Crowe JP, Dickinson RJ, Green JRB, Banerjee S, Dronfield et al. Reflux oesophagitis resolves more rapidly with omeprazole 20 mg once daily than with ranitidine 150 mg twice daily: omeprazole 40 mg once daily provides further benefit in unresponsive patients. Br J Clin Res 1991;2:133–48.
   Google Scholar
• Collen MJ, Strong RM. Comparison of omeprazole and ranitidine in treatment of refractory gastroesophageal reflux disease in patients with gastric acid hypersecretion. Dig Dis Sci 1992;37:897–903.
   PubMed Web of Science ®Google Scholar
• Erikson S, Langström G, Rikner L, Carlsson R, Naesdal J. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a metaanalysis. Eur J Gastroenterol Hepatol 1995;7:467–75.
   PubMed Web of Science ®Google Scholar
• Koop H, Hotz J, Pommer G, Klein M, Arnold R. Prospective evaluation of omeprazole treatment in reflux oesophagitis refractory to H2-receptor antagonists. Aliment Pharmacol Ther 1990;4: 593–9.
   Google Scholar
• Koop H, Schepp W, Dammann HG, Schneider A, Lühmann R, Classen M. Comparative trial of pantoprazole and ranitidine in the treatment of reflux esophagitis. Results of a German multicentre study. J Clin Gastroenterol 1995;20:192–5.
   Google Scholar
• Koop H, Arnold R. Long-term maintenance treatment of reflux esophagitis with omeprazole. Prospective study in patients with H2-blocker-resistant esophagitis. Dig Dis Sci 1991;36: 552–7.
   Google Scholar
• Lind T, Cederberg C, Idström J-P, Lonroth H, Olbe L, Lundell L. 24-hour intragastric acidity and plasma gastrin during longterm treatment with omeprazole or ranitidine in patients with reflux esophagitis. Scand J Gastroenterol 1991;26: 620–6.
   Google Scholar
• Lundell L, Backman L, Ekström P, Enander L-K, Falkmer S, Fausa O, et al. Prevention of relapse of reflux esophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine. Scand J Gastroenterol 1991;26:248–56.
   Google Scholar
• Lundell L, Backman L, Ekström P, Enander L-K, Falkmer S, Fausa O, et al. Omeprazole or high-dose ranitidine in the treatment of patients with reflux oesophagitis not responding to ’standard doses’ of H2-receptor antagonists. Aliment Pharmacol Ther 1990;4: 145–55.
   Google Scholar
• Marks RD, Richter JE, Rizzo J, Koehler RE, Spenney JG, Mills TP, et al. Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis. Gastroenterology 1994;106:907–15.
   PubMed Web of Science ®Google Scholar
• Ruth M, Enbom H, Lundell L, Lönroth H, Sandberg N, Sandmark S. The effect of omeprazole or ranitidine treatment on 24-hour esophageal acidity in patients with reflux esophagitis. Scand J Gastroenterol 1988;23: 1141–6.
   Google Scholar
• Vigneri S, Termini R, Leandro G, Badalamente S, Pantalena M, Savarino V, et al. A comparison of five maintenance therapies for reflux esophagitis. N Engl J Med 1995;333:1106–10.
   PubMed Web of Science ®Google Scholar
• Jarvis LR, Dent J, Whitehead R. Morphometric assessment of reflux oesophagitis in fiberoptic biopsy specimens. J Clin Pathol 1985;38:44–8.
   Google Scholar
• Geboes K, Desmet V, Vantrappen G, Mebis J. Vascular changes in the esophageal mucosa. An early histologic sign of esophagitis. Gastrointest Endosc 1980;26:29–32.
   PubMed Web of Science ®Google Scholar
• Kobayashi S, Kasugai T. Endoscopic and biopsy criteria for the diagnosis of esophagitis with a fiberoptic esophagoscope. Am J Dig 1974;19:345–52.
   PubMedGoogle Scholar
• Sbarbat A, Ricci F, Inaspettato G, Lazzara G, Cordiano C, Osculati F. Microvascular lesions in reflux oesophagitis and Barrett’s oesophagus. J Pathol 1994;173:61–3.
   PubMed Web of Science ®Google Scholar